Kymera Therapeutics


Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Industries

Employees

51-200

Links


Org chart

Hiring!

Nello Mainolfi
Co-Founder, President & CEO
Collapse
Jared Gollob
Chief Medical Officer
Karen Weisbach
VP, People & Culture
Aimee Mishkin
VP, Regulatory Affairs
Noah Goodman
Chief Business Officer
Mike Legato
Senior Director, IT Applications
Matt Foroughi
Senior Manager, Cybersecurity
Chad Nivens
Vice President
Matthew Weiss
Vp, Head Of Chemistry And Early Drug Discovery
Lea Florentino
Executive Business Partner To The CEO
Randy Barnes
Executive Director, CMC Technical Operations
Keith Fleischer
Director, Contracts Counsel

Board & advisors

Bruce Booth
Co-Founder & Chairman
Jeff Albers
Director
Leigh Morgan
Director
Steven A. Carr
Scientific Advisor
Jean-Laurent Casanova
Scientific Advisor
David Frank
Scientific Advisor
Nick Keen
Scientific Advisor
Antonio Sica
Scientific Advisor
David Spiegel
Scientific Advisor
Robert Terkeltaub
Scientific Advisor